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Abstract 
Background: Coronary heart disease (CHD) is the leading cause of death in United State (U.S.). Controlling of 
modifiable risk factors such as smoking, hypertension (HT), diabetes mellitus (D.M.), dyslipidemia, physical 
inactivity & obesity will prevent other serious cardiovascular complications. 
Objective: This study was designed to determine the adherence of the patients who were known to have 
ischemic heart disease (I.H.D.) to the ACC/ AHA Guidelines of secondary prevention of I.H.D. 
Patients  and  methods : This is an outpatient  base  study ,was  conducted at the Iraqi Center of  Heart Disease  
outpatient clinic  from    1st. of  October  2009 till 31st. of  March  2010.Where  two  hundred & forty tow  (242) 
patients were selected. Variable data were taken from the patients as follows: age, gender.  Level of education, 
type of I.H.D., smoking habits, body weight &height, hypertensive patients, the control of blood sugar by 
measuring of HbA1c level for the diabetic patients. Fasting lipid profile, renal function testes, Hb also were 
tested. Baseline cardiac investigations in  form of CXR, ECG, Echocardiography , TMT & previous coronary 
angiography were reviewed  & finally several questioners for the patients regarding their disease, risk factors, 
cardio protective drugs &times of visits their physicians during a month.                        
Results:  One hundred & sixty seven patients (69%) were smokers, (65%) of them quit smoking. (64%) were 
hypertensive, 57 % of them had uncontrolled HT. 16.5 % were diabetics, 90% of them had uncontrolled D.M. 
which is estimated by measurement of Hb1Ac < 7%. (69%) were overweight, 24.4% of them were obese.  
Conclusion: Most of the patients included in the study were not reaching a goal according to AHA/ACC 
Guidelines of secondary prevention apart from quit smoking & this may put them at high risk of development of 
further life threatening cardiovascular events like: recurrent ischemia, acute coronary syndrome, heart failure or 
even death.     
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Introduction:  Cardiovascular disease (CVD) is the leading cause of death & disability in developed nations & 
is increasing rapidly in the developing world (1). Precipitation of the crucial role of risk factors in the 
Development of coronary heart disease (CHD) is one of the most significant advances in the understanding of 
this important disease. 
Extensive epidemiological research has established cigarette smoking, diabetes. Dyslipidemia & hypertension as 
independent risk factors for CHD. In addition, treatment of these risk factors has been shown to reduce the risk 
of further cardiac event (2). IHD is the most common serious chronic life threating illness in U.S. where 13 
million persons have IHD; more than 6 million have angina pectoris & more than 7 million with acute 
myocardial infarction (MI) (3). 
. 
Atherosclerosis is a complex arterial disease in which cholesterol deposition; inflammation, extracellular matrix 
&thrombus formation play major roles (4). Atherosclerotic cardiovascular disease refers to the diffuse condition of 
atherosclerosis involving the heart (coronary arteries), brain (carotid, vertebral & cerebral arteries), aorta & 
peripheral arteries. Most of the risk factors that apply to one arterial bed also apply to others .coronary 
atherosclerotic disease include a wide range from silent ischemia & exertion induce angina to the acute coronary 
syndrome (ACS).stable angina (usually exertional) or stable silent ischemia commonly result from increases in 
myocardial oxygen demand that outstrip the ability of stenosed coronary arteries to increase oxygen delivery (5). 
In contrast ,ACS is characterized  by an abrupt  mismatch ,with about one third caused by increase in myocardial 
O2 demand & two third caused by a thrombotic occlusion related to local vessel wall substrates( i.e. plaque 
ulceration  or  erosion),rheology (high shear stress after plaque distruption or distortion ,vasoconstriction ) & 
systemic factors (i.e. blood hyperthrombogenicity ) (5). Such factors also contribute in various consequences, to 
whether the ACS is manifested clinically as UA/ NSTEMI or STEMI. 
 
Risk Factors of I.H.D. 
Modifiable risk factors: include Cigarette smoking, Hypertension, Diabetes mellitus, Obesity (BMI > 3O Kg / 
m2), Physical inactivity, Dyslipidemia (which is defined by any of the following, total serum cholesterol > 200 
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mg/dl, S.TG >150 mg /dl, LDL-cholesterol level >100 mg/dl. or HDL-cholesterol >40 mg/dl in male > 50mg/dl 
in female (6) 
 
Non modifiable risk factors: include, Age (men > 45 years, women > 55 years) Family history of premature 
CAD (CAD in male 1st. degree relative < 55 years, CAD in female 1st.degree relative <65 years) or SCD (6).  
 
Emerging (Novel ) risk factors (7): C-reactive protein,  Lipoprotein  a, Fibrinogen, Homocystein,  Although these 
Novel (emerging ) risk factors are associated with  vascular disease risk , their optimal use in routine screening 
& risk stratification remains to be determined (8) . 
 
Adherence to cardio protective medication: The cardioprotective drugs include: Antiplatelets, Statins, B 
Blockers, and Renin-angiotensin –aldosteron blockers. Medication adherence is associated with improve 
outcome among patients with diabetes &IHD.  The goal is to use ACC/AHA guidelines to provide feedback to 
hospital & physician regarding their use of appropriate therapy. The success of this program will restart the 
ability of continuous quality improvement process to guide clinicians to optimal approach using ACC/AHA 
guidelines (9). 
 
Aim of study: To evaluate the adherence of patients who were known to have IHD according to the ACC/AHA 
guidelines of secondary prevention of IHD. 
 
Patients and methods:                                                                                    
The Cross sectional descriptive study was performed in the Iraqi Center for heart Diseases. Total of two hundred 
& forty two (242) patients who were attending the outpatient clinic from 1st.of October 2009 till 31st. of March 
2010 were selected. Each had a full  history & clinical examination including  assessment of  coronary risk  
factors, Age, Smoking(smokers, nonsmokers or quit smoking (stop smoking for less than 2 years) ),HT, D.M, 
Obesity, physical inactivity ,dyslipidemia & family history of premature C.A.D. or SCD, We select 2 types of 
presentations, those with stable angina & those with  STEMI . 
 
Blood sample were taken  from all pahents to measure fasting Blood sugar, Hb A1c, blood urea, serum creatinin, 
Hb level &fasting serum  lipid profile  & readings  were categorized as well controlled or dyslipidemic. 
dyslipidedmia was defined by any of the followings, Total serum cholesterol > 200 mg /dl, Serum LDL-
cholesterol > 1oo mg/dl, Serum  HDL-cholesterol < 40 mg /dL  in men  & < 50 mg /dl in women and Serum  TG  
> 150 mg/dl. 
 
Cardiological assessment including CXR, ECG, TMT, TTE & coronary angiography were performed & looking 
for significant CXR finding like Cardiomegaly, pleural effusion (unilateral or bilateral) ,venous congestion 0r 
Kerly B- line (interstitial oedema). On other hand significant ECG finding include: ST-T changes, LBBBB, 
LVH, pathological Q-wave or poor progression of  R-wave .  Body mass index (BMI) was calculated according 
to the equation,  BMI = body weight in Kg / height in square meter & categorized as normal BMI ( 18- 24.9 
Kg/m² ),Overweight (25-29.9 Kg/m² ),  Obese ( >30 9Kg/m2). Diabetes mellitus defined as: polyuria or 
polydipsia plus random blood glucose concentration more than 200 mg /dl or fasting plasma glucose more than 
126 mg/dl or 2 hours plasma glucose more than 200mg/dl during oral glucose tolerance test, or previous history 
of D.M. on oral hypoglycemic medication or insulin therapy.  Blood samples were taken from diabetic patients 
to measure HbA1c &their reading were tabulated as well controlled (< 7%) 0r uncontrolled (> 7%).                                   
 
Hypertension defined as: BP of 140/90mmHg or more, in two or more separated occasions, or history of 
hypertension on antihypertensive medication. Hypertensive patient categorized as controlled if BP< 140/90 
mmHg or uncontrolled if BP >140/90mmHg.  Previous coronary angiography or percutaneous coronary 
intervention reports were reviewed & the patients were classified to have (one ,two, three, four vessels disease or 
LMS lesion.) Several questions were asked to the patient about the diagnosis of their disease, risk factors of 
CAD &cardioprotective drugs & the frequency of  visiting their physicians monthly & how they adhere to 
instructions provided by their treating physicians.  
 
Exclusion criteria: include the followings, UA/NSTEMI, previously known primary valvular heart disease, 
Congenital heart disease, peripheral vascular disease, previous CABG.   
 
Statistical  analysis:  All data were coded & enter to the computer by using statistical package of social science 
(SPPS 15 ) associated between different variables were measured by using Chi square test. Multiple linear 
regression models were used to differentiate between dependent & independent risk factors. P value below 0.05 
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consider as level of significance. 
 
Results:                 
The age range of study was (35-72 year) & median age of 53.48 year & median of 53.40 + 2SD 7.628. The 
distribution of patients according to age as shown in table (1) that show the majority of  sample (40%)  fall in 
age group ( 50-59) &the minority  of them ( 2.5%) fall in age of <40.   
                                                                   
Table (1) distribution of patients according to age. 
Age  group (year) No. % 
< 4o 6 2.5 % 
40-49 64 26 % 
50-59 98 40 % 
60-69 54 22 % 
>70 18 7 % 
Total 242 100 % 
 
Table (2) distribution of patient according to gender, the table illustrate more than 2/3 0f sample were male. 
 
% No. Gender 
18 % 44 Female 
82 % 198 Male  
100 % 242 Total 
 
Table (3) Distribution of patients according to the risk factors 
The table showed that 1.156 pt.( 64%)were hypertensive , 43% of them had controlled HT & 57%had 
uncontrolled HT.  
2. 40 .pt. (16.5) were diabetic, 10% of them had controlled diabetes & 90% had uncontrolled diabetes. 
3.161(66%) were dyslipidemia                                                                                   4. 167(69%) had overweight, 
24.4 were obese 
5. 167(69%) were smokers, 65% quit smoking & 35% current smokers.           
6. 33 (13.6%) had positive family history of premature CAD                               
 
Risk factor Controlled 
 
Uncontrolled Total 
No. % No. % No. % 
Hypertension 67 43 % 89 57 % 156 64 % 
Diabetes 4 10 % 36 90 % 40 16.5 
Body mass index 121* 73.3 % 46** 24.4% 167*  69 % 
Smoking 109 65 % 58 35 % 167  69 % 
Family history 209 86.4 % 33 13.6 % 242 100 % 
Dyslipidemia 81 34.4 % 161 65.9 % 242 100 % 
 
* mean over weight  
** mean obese 
 
-The table (4) shows that: 
1. (78%) of the studied sample had significant ECG finding (ST-T changes, LBBB, LVH, pathological Q-wave 
or poor progression of R-wave) .the table also illustrate that about 41% of patients had significant CXR finding 
(cardiomegaly, venous congestion, pleural effusion or Kerly B-line (interstitial edema).                     
2. About one third of patients had EF less than 40%, 152 (62.8%) of patients have no TMT, the reasons either 
they were at high risk regarding test of probability or STEMI patients or this was the opinion of their physicians. 
Two third of patients has high level of S.LDL, 62 % has decreased level of S.HDL, 53% has increased level of 
S.TG, 42 % has increased level of S. Cholesterol.  
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Table(4): Baseline cardiac investigations  of studied sample          
Test   Non significant Significant 
 
No.  % No.  % 
ECG 51  22 % 197 78 % 
CXR 143 59.1 % 99 40.9 % 
EF 159* 65.7 % 83** 34.3 % 
TMT 152 62.8 % 90 37.2 % 
* mean EF > 40 % 
** mean EF< 40 % 
 
The table (5) showed significant association between gender, conventional risk factors &no. of affected coronary 
arteries.  
 
Table (5): number of affected vessel according to risk factors                                                                      
 
 
p-value 
Total Four 
vessel 
Three 
vessel 
Two 
Vessel 
One  
vessel 
Normal 
vessel 
 
 
Risk factor 
 
% No. % No. % No. % No. % No. % No. 
 
0.03 
18.2 44 0 0 10 3 10.1 7 12.5 8 4.7 26 Female  
Gender 
81.8 148 100 4 90 27 89.9 62 87.5 56 65.3 49 Male 
 
 
 
 
0.02 
35.5 86 0 0 21.7 3 30.4 21 45.3 29 44 33 Not HT 
 
 
Hypertension 
27.7 67 0 0 36.7 11 21.7 15 12.5 8 44 33 Controlled 
HT 
36.8 89 100 4 53.3 16 47.8 33 42.2 27 12 9 Uncontrolled 
HT 
 
 
 
 
0.03 
83.5 202 100 4 46.7 14 72.5 50 100 64 93.3 70 No DM 
 
Diabetes 
Mellitus 
1.7 4 0 0 0 0 5.8 4 0 0 0 0 Controlled DM 
 
14.9 36 0 0 53.3 16 21.7 15 0 0 6.7 5 Uncontrolled DM 
 
 
 
0.04 
23.6 57 100 4 26.7 8 26.1 18 18.8 12 20 15 Normal  
BMI 
50 121 0 0 46.7 14 26.1 18 65.6 42 62.7 47 Overweight 
26.4 64 0 0 26.7 8 47.8 33 15.6 10 17.3 13 Obese 
 
 
 
0.02 
34 81 0 0 22.7 8 29.3 15 67.9 31 52.9 27 No dyslipidemia  
Dyslipidemia 
66 161 0 0 77.3 30 70.7 56 32.1 26 47.1 43 Dyslipidemia 
 
 
 
 
0.042 
31 75 
  
10 3 20.3 14 20.3 13 60 45 Not smoking 
 
 
smoking 
45 109 
  
36.7 11 53.6 37 45.3 29 37.3 28 Quit smoking 
24 58 
  
53.3 16 26.1 18 34.4 22 2.7 2 Smoker 
 
 
 
0.001 
86.4 209 100 4 86.7 26 88.4 61 71.9 46 96 72 Negative 
 
Family history 
13.6 33 
  
13.3 4 11.6 8 28,1 18 4 3 Positive 
242 4 30 69 64 75 Total Number  
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Table (6): the distribution of answers of the patients to 7 questions answers for the patient’s sample                                             
                                                                                                         
 
                                                                  
The table shows most of the studied patients know their clinical diagnosis, type of treatment, role of risk factors 
in CHD & most of them visit their physician twice monthly. 
 
DISCUSSION: 
The majority of patients  fall in age group (50-59 year).Framingham Heart Study Investigators categorize the 
patients according to their age in groups &estimate the ten years risk for development of cardiovascular events, 
that range from (30-34 yr.) 3% to (70-74 yr.) 30 % (10).This demonstrate  that  our patients were seventeen year 
younger  than   in Framingham ´s, probably due to consumption of unhealthy diet which is rich in fat, poor 
awareness about the importance of achieving better control of risk factors such as hypertension ,diabetes and 
hyperlipidemia  and also because of poor drug compliance.  
 
Most patients in the study fall in category of overweight, which was estimated by BMI (25-29.9 Kg/m²). In this 
study 69% of patients were overweight, of whom 24.4% are obese.  As compare to NHANES study in US which 
show 64.5%of men &women were overweight, of whom 30.5% were obese (11). In this study 69% of the patients 
were overweight & were not adhere to guidelines & their physicians advises about programs of weight reduction 
,regular physical activity & healthy diet ,or improper advise was given by their treating physicians as a 
consequence  ,this may lead to  uncontrolled HT ,D.M. &lipid metabolism & add more adverse cardiovascular 
events & mortality. 
 
In this study 69% of patients were smokers, 65% of them quit smoking while 35% still smoking that is mean, 
most of the smokers quit their smoking habit, possibly because of good advice by their physician & patient 
adherence. Clinical practice guidelines from the U.S. Public Health Services recognize that tobacco dependence 
is a chronic condition that generally requires repeated intervention, they recommend asking patient about 
tobacco use at every visit, a strategy supported by the U.S. Preventive Services Task Force (12).  
The total number of  diabetic patients in the study was 40 ,only 10%  of them had controlled diabetes that is 
estimated by measuring of HbA1c level which is < 7%  as recommended by AHA/ACC guidelines & 90% had 
uncontrolled D.M. which is estimated by HbA1c level which is > 7%. In U.S. 7 % of population have D.M. , 
approximately 90% are type 2 D.M(13). One third of people with diabetes are not aware that they have the 
disease. The prevalence of diabetes appears to have increased over the last decade which may be a reflection of 
increasing BMI (14).  
 
Patient who were included in the study were not reaching the require limit of diabetic control according to the 
guidelines & did not follow their physician advise about weight reduction , regular exercise, healthy diet & 
medication ,probably because of  poor communication between the patient & their physician & poor 
circumstances that may prevent the patient from regular medical visits to  obtain  their  proper medication. About 
two third of patients in the study were hypertensive, 57% of them had uncontrolled HT (BP > 140/90 mmHg).  
The prevalence of HT increases with age, from 7% of those aged 18 – 34 yr. to 66% of those older than 60 years 
(15)
. In the U.S.  HT prevalence appears to be increasing. Although control of HT improved throughout the 1990s, 
particularly among older patients, control rate remain low (30%) (16, 17).  Studied have consistently demonstrated 
that elevated systolic or diastolic BP is associated with increased risk of CVD (18).  
 
 
No Yes Questions 
% No. % No. 
 
26 63 74 179 Q1/Do you know your clinical diagnosis?       
 
17.4 42 82.6 200 Q2/Do you know what are types of investigations & medications did you 
receives during hospitalization? 
 
18.2 44 81.8 198 Q3/  Do you know the cause of your disease? 
 
31.8 77 68.2 165 Q4/What is your opinion about the risk factors of CHD?     
 
74.8 181 25.2 61 Q/5 Dou you know the drugs that used for your disease?    
 
28.1 68 71.9 174 Q6/Did any physician in the center explain to you any of the risk factors of 
CHD? 
 
On need Twice 
monthly 
Once 
monthly 
Q7/ How many times you are visiting your physician during a month? 
12.8 30 71.9 175 15.3 37 
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In the study 57% of hypertensive patients were not at the required level of BP control, probably due to poor 
communication with their physician, inability to obtain their proper medication & achieve a healthy diet with 
low salt & fat & rich in fruits & vegetables. Poor drug compliance also plays a role. 
 
Tow third of patients included in the study had dyslipidemia according to the cutoff point mentioned in the 
AHA/ACC guidelines.  50% of American adults have cholesterol level > 200mg/dl (19). Fasting TG level 
represent a useful marker of the risk of CHD ,so it is atherogenic & meta-analysis suggest that elevated TG  level 
is an important risk factor for CHD & mortality(20).  In the study, two third of the patients had dyslipidemia, that 
is mean they are not adher to guidelines & this lead to increase the risk of developing serious adverse 
cardiovascular events & death.  
 
Conclusion: Only smoking was reasonably controlled as 65% of smokers were succeeded to quit his habit and 
Most of the diabetic patients had uncontrolled blood sugar level which was estimated by HbA1c level  
57% of Hypertensive patients were not achieving the target of BP control (< 140\90 mmHg) and two third of 
patients still out of control of their lipid profile as recommended by NCEP panel 3. 
More than two third of patients were overweight, quarter of them were obese and 
more than two third of patients know their clinical diagnosis, quarter of patients know their medications & more 
than two third of patients visit their physician twice monthly . 
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